Voyager Therapeutics, Inc.

VYGR

$3.38

-4.52%

N/A-$0.16

Healthcare

Biotechnology

NASDAQ

Active Trading

Voyager Therapeutics, Inc. operates as a gene therapy company, concentrating its efforts on developing innovative treatments and pioneering advanced platform technologies. Its ...

Insider Transactions of VYGR

Acquisitions (A)

Since May 8, 2026

Disposals (D)

Since May 8, 2026

Monthly shares of acquisitions/disposals with close price trend (shared daily price source)

Insider Trading Snapshot

Date	Executive	Title	Security	Side	Shares	Price
Jun 9, 2026	SCANGOS GEORGE A	director	Stock Option (Right to Buy)	A	30,000	$3.43
Jun 9, 2026	MACKEY CATHERINE J	director	Stock Option (Right to Buy)	A	30,000	$3.43
Jun 9, 2026	Hyman Steven	director	Stock Option (Right to Buy)	A	30,000	$3.43
Jun 9, 2026	Vitale Nancy	director	Stock Option (Right to Buy)	A	30,000	$3.43
Jun 9, 2026	Higgins Michael J	director	Stock Option (Right to Buy)	A	30,000	$3.43

Insider Trading Snapshot

Acquisitions (A)

Disposals (D)

Total Shares Bought

270,000

Total Shares Sold

Monthly Insider Activity

Monthly shares of acquisitions/disposals with close price trend (shared daily price source)

Transactions by Title - Shares

X-axis: shares, sorted by total shares desc

Transactions by Title - Counts

X-axis: counts, sorted by A+D counts desc

Key People: Buy/Sell Activity and Price

SCANGOS GEORGE A

director • 1 txns

MACKEY CATHERINE J

director • 1 txns

Hyman Steven

director • 1 txns

Vitale Nancy

director • 1 txns

Transactions Table

Date	Executive	Title	Security	Side	Shares	Price	Value
Jun 9, 2026	SCANGOS GEORGE A	director	Stock Option (Right to Buy)	A	30,000	$3.43	$102,900.00
Jun 9, 2026	MACKEY CATHERINE J	director	Stock Option (Right to Buy)	A	30,000	$3.43	$102,900.00
Jun 9, 2026	Hyman Steven	director	Stock Option (Right to Buy)	A	30,000	$3.43	$102,900.00
Jun 9, 2026	Vitale Nancy	director	Stock Option (Right to Buy)	A	30,000	$3.43	$102,900.00
Jun 9, 2026	Higgins Michael J	director	Stock Option (Right to Buy)	A	30,000	$3.43	$102,900.00
Jun 9, 2026	Onyia Jude	director	Stock Option (Right to Buy)	A	30,000	$3.43	$102,900.00
Jun 9, 2026	GERAGHTY JAMES A	director	Stock Option (Right to Buy)	A	30,000	$3.43	$102,900.00
Jun 9, 2026	Colon Grace	director	Stock Option (Right to Buy)	A	30,000	$3.43	$102,900.00
Jun 9, 2026	PIERCE GLENN	director	Stock Option (Right to Buy)	A	30,000	$3.43	$102,900.00
May 8, 2026	Quinlan Amy	officer: Principal Accounting Officer	Common Stock	—	0	—	—

Upstream

FUJIFILM Biotechnologies (formerly FUJIFILM Diosynth Biotechnologies)TYO:4901Thermo Fisher Scientific Inc. (via Brammer Bio acquisition)NYSE:TMOMassBiologics (University of Massachusetts Chan Medical School)REGENXBIO Inc.NASDAQ:RGNXPlasmid DNA & Raw Material Suppliers (Multiple suppliers – cell culture media, reagents, plasmids, enzymes)

Downstream

Neurocrine Biosciences, Inc.NASDAQ:NBIX Novartis Pharma AGNYSE:NVS Pfizer Inc.NYSE:PFE Alexion, AstraZeneca Rare DiseaseNASDAQ:AZN Sangamo Therapeutics, Inc.NASDAQ:SGMO

Proxies

Neurocrine Biosciences, Inc.NASDAQ:NBIX Sangamo Therapeutics, Inc.NASDAQ:SGMO REGENXBIO Inc.NASDAQ:RGNX uniQure N.V.NASDAQ:QURE

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer

No matching stocks found

Voyager Therapeutics, Inc.

Insider Transactions of VYGR

Insider Trading Snapshot

Monthly Insider Activity

Transactions by Title - Shares

Transactions by Title - Counts

Key People: Buy/Sell Activity and Price

Transactions Table

Supply Chain of VYGR

Upstream

Downstream

Proxies

Insider Transactions of VYGR

Insider Trading Snapshot

Monthly Insider Activity

Transactions by Title - Shares

Transactions by Title - Counts

Key People: Buy/Sell Activity and Price

Transactions Table

Supply Chain of VYGR

Upstream

Downstream

Proxies